Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Bodey

Showing results (141-150 of 726) with videos related to

Pageof 73
Sort By:
Antimicrobial Agents and Chemotherapy|January 1, 1978
PC-904, a new semisynthetic penicillinG P Bodey, S Weaver, T Pan
Cancer|October 1, 1973
Management of fever of unknown origin in patients with neoplasms and neutropeniaV Rodriguez, M Burgess, G P Bodey
The American Journal of the Medical Sciences|December 1, 1973
Clinical pharmacology of tobramycinN Horikoshi, M Valdivieso, G P Bodey
Cancer|February 1, 1974
Proceedings: Causes of death in cancer patientsJ Inagaki, V Rodriguez, G P Bodey
Clinical Pharmacology and Therapeutics|July 1, 1972
Flucloxacillin: a new semisynthetic isoxazolyl penicillinG P Bodey, C Vallejos, D Stewart
Clinical Pharmacology and Therapeutics|March 1, 1970
Gentamicin sulfate distribution in body fluidsV Rodriguez, D Stewart, G P Bodey
Antimicrobial Agents and Chemotherapy|September 1, 1982
In vitro susceptibilities of Aeromonas hydrophila against new antibioticsV Fainstein, S Weaver, G P Bodey
Antimicrobial Agents and Chemotherapy|February 1, 1982
Comparative in vitro study of SQ26,776V Fainstein, S Weaver, G P Bodey
Cancer Treatment Reports|August 1, 1980
Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphomaF Cabanillas, V Rodriguez, G P Bodey
Cancer Treatment and Research|January 1, 1995
Pneumonia in cancer patientsE Whimbey, J Goodrich, G P Bodey
Pageof 73

Showing results (141-150 of 726) with videos related to

Sort By:
Pageof 73
Antimicrobial Agents and Chemotherapy|January 1, 1978
PC-904, a new semisynthetic penicillinG P Bodey, S Weaver, T Pan
Cancer|October 1, 1973
Management of fever of unknown origin in patients with neoplasms and neutropeniaV Rodriguez, M Burgess, G P Bodey
The American Journal of the Medical Sciences|December 1, 1973
Clinical pharmacology of tobramycinN Horikoshi, M Valdivieso, G P Bodey
Cancer|February 1, 1974
Proceedings: Causes of death in cancer patientsJ Inagaki, V Rodriguez, G P Bodey
Clinical Pharmacology and Therapeutics|July 1, 1972
Flucloxacillin: a new semisynthetic isoxazolyl penicillinG P Bodey, C Vallejos, D Stewart
Clinical Pharmacology and Therapeutics|March 1, 1970
Gentamicin sulfate distribution in body fluidsV Rodriguez, D Stewart, G P Bodey
Antimicrobial Agents and Chemotherapy|September 1, 1982
In vitro susceptibilities of Aeromonas hydrophila against new antibioticsV Fainstein, S Weaver, G P Bodey
Antimicrobial Agents and Chemotherapy|February 1, 1982
Comparative in vitro study of SQ26,776V Fainstein, S Weaver, G P Bodey
Cancer Treatment Reports|August 1, 1980
Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphomaF Cabanillas, V Rodriguez, G P Bodey
Cancer Treatment and Research|January 1, 1995
Pneumonia in cancer patientsE Whimbey, J Goodrich, G P Bodey
Pageof 73